Renal function improvement with pentavalent antimonial agents in patients with visceral leishmaniasis

American Journal of Nephrology

Volumn 33, Issue 4, 2011, Pages 332-336

  Daher, Elizabeth F ^a,b,e   Rocha, Natália A ^a   Oliveira, Michelle J C ^a,b   Franco, Luiz F L G ^a   Oliveira, Jobson L ^a   Silva Junior, Geraldo B ^a,b,c   Abreu, Krasnalhia Lívia S ^a   Henn, Guilherme A L ^d   Martins, Alice M C ^b   Libório, Alexandre B ^c  

^a Division of Nephrology   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^c UNIVERSITY OF FORTALEZA   (Brazil)

^d Sao Jose Infectious Diseases Hospital   (Brazil)

^e NONE   (Brazil)

Author keywords

Acute kidney injury; DDAVP; Kala azar; Urinary acidification; Urinary concentration; Visceral leishmaniasis

Indexed keywords

CALCIUM CHLORIDE; MEGLUMINE ANTIMONATE; POTASSIUM; PROTEIN; SODIUM; WATER;

ADULT; ALBUMINURIA; ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FREE WATER CLEARANCE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MALE; PLASMA OSMOLALITY; POTASSIUM EXCRETION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; SODIUM EXCRETION; TUBULAR DYSFUNCTION; URINARY EXCRETION; URINE OSMOLALITY; URINE PH; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY; KIDNEY FUNCTION TESTS; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; POTASSIUM; PROSPECTIVE STUDIES; SODIUM;

EID: 79952580818     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324914     Document Type: Article

References (25)

1. Camargo LB, Langoni H: Impact of leishmaniasis on public health. J Venom Anim Toxins incl Trop Dis 2006; 12: 527-548.
2. Efstratiadis G, Boura E, Giamalis P, et al: Renal involvement in a patient with visceral leishmaniasis. Nephrol Dial Transplant 2006; 21: 235-236.
3. Guerin PJ, Olliaro P, Sundar S, et al: Visceral leishmaniasis: current status of control, dianosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002; 2: 494-501.
4. Herwaldt BL: Leishmaniasis. Lancet 1999; 354: 1191-1199.
5. Albuquerque PL, Silva Júnior GB, Freire CC, Oliveira SB, Almeida DM, Silva HF, Cavalcante MS, Sousa AQ: Urbanization of visceral leishmaniasis (kala-azar) in Fortaleza, Ceará, Brazil. Rev Panam Salud Pública 2009; 26: 330-333.
6. Olliaro PL, Guerin PJ, Gerstl S, Haaskjold AA, Rottingen JA, Sundar S: Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. Lancet Infect Dis 2005; 5: 763-774.
7. Salgado Filho N, Ferreira TMAF, Costa JML: Involvement of the renal function in patients with visceral leishmaniasis (kala-azar). Rev Soc Bras Med Trop 2003; 36: 217-221.
8. Oliveira MJ, Silva Júnior GB, Abreu KL, Rocha NA, Garcia AV, Franco LF, Mota RM, Libório AB, Daher EF: Risk factors for acute kidney injury in visceral leishmaniasis (kala- azar). Am J Trop Med Hyg 2010; 82: 449-453.
9. Daher EF, Evangelista LF, Silva Júnior GB, et al: Clinical presentation and renal evaluation of human visceral leishmaniasis (kalaazar): a retrospective study of 57 patients in Brazil. Braz J Infect Dis 2008; 12: 329-332.
10. Oliveira AL, Brustoloni YM, Fernandes TD, Dorval ME, Cunha RV, Bóia MN: Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil. Trop Doct 2009; 39: 180-182.
11. Beltrame A, Arzese A, Camporese A, et al: Acute renal failure due to visceral leishmaniasis by Leishmania infantum successfully treated with a single high dose of liposomal amphotericin B. J Travel Med 2008; 15: 358-360.
12. Navarro M, Bonet J, Bonal J, Romero R: Secondary amyloidosis with irreversible acute renal failure caused by visceral leishmaniasis in a patient with AIDS. Nefrologia 2006; 26: 745-746.
13. Rollino C, Bellis D, Beltrame G, et al: Acute renal failure in leishmaniasis. Nephrol Dial Transplant 2003; 18: 1950-1951.
14. Lima Verde FAA, Lima Verde FA, Lima Verde IA, et al: Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study of 50 patients from Brazil. J Nephrol 2007; 20: 430-436.
15. Mongensen CE: Prediction of clinical diabetic nephropathy in IDDM patients: alternatives to microalbuminuria. Diabetes 1990; 39: 761-767.
16. Tryding N, Sterner G, Berg B, Harris A: Subcutaneous and intranasal administration of 1-deamino-8-d-arginine vasopressin in the assessment of renal concentration capacity. Nephron 1987; 45: 27-30.
17. Oster JR, Hotchkiss JL, Carbon M, Farmer M, Vaamonde CA: A short duration renal acidification test using calcium chloride. Nephron 1975; 14: 281-289.
18. De Brito T, Hoshino-Shimizu S, Neto VA, Duarte IS, Penna DO: Glomerular involvement in human kala-azar: a light immunofluorescent and electron microscopic study based on kidney biopsies. Am J Trop Med Hyg 1975; 24: 9-18.
19. Gerstein HC, Mann JF, Yi Q, et al: Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and non-diabetic individuals. JAMA 2001; 286: 421-426.
20. Ismail N, Becker B, Strzelczyk P, Ritz E: Renal disease and hypertension in non-insulindependent diabetes mellitus. Kidney Int 1999; 55: 1-28.
21. Eknoyan G, McDonald MA, Appel D, Truong LD: Chronic tubulo-interstitial nephritis: correlation between structural and functional findings. Kidney Int 1990; 38: 736-743.
22. Feldman BJ, Rosenthal SM, Vargas GA, et al: Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med 2005; 352: 1884-1890.
23. Cogan MG: Tubulointerstitial nephropathies: a pathophysiological approach. West J Med 1980; 132: 134-140.
24. Morris RC, Fudenberg HH: Impaired renal acidification in patients with hypergammaglobulinemia. Medicine 1967; 46: 57-69.
25. Russo LM, Bakris GL Comper WD: Renal handling of albumin: a critical review of basic concepts and perspective. Am J Kidney Dis 2002; 39: 899-919.